VTYX (Ventyx Biosciences Inc.) Sof foyda

VTYX (Ventyx Biosciences, Inc.) - kompaniyaning tovar belgisi

Ventyx Biosciences tibbiy patologiyalar uchun immunitetni kuchaytiruvchi agentlar va terapiyalarni ishlab chiqishga ixtisoslashgan. Kompaniya tadqiqot ustuvorliklaridagi strategik o'zgarishdan so'ng ayni paytda aksiyadorlar sodiqligini qayta tiklamoqda, bunda ko'rsatkich -0.10 darajasida turibdi. GURU.Markets platformasidagi ushbu grafik aktivning narx harakatlarini aks ettiradi. Biznes avtoimmun jarayonlarga qarshi kurashish uchun oral dori vositalarini ishlab chiqarishga e'tibor qaratgan bo'lib, murakkab inyeksiyalarni qulayroq yuborish shakllari bilan almashtirishni maqsad qilgan.

VTYX (Ventyx Biosciences) Sof foyda tarixi 04.07.2022dan 14.03.2026gacha

Ventyx Biosciences, Inc. (VTYX) kompaniyasining tahliliy kesimlari va maʼlumotlar hisoboti

- narx va narxlar bo'yicha konsensus prognoz:
Aksiya kotirovkalari Ventyx Biosciences, Inc|VTYX - Tahlilchilar konsensus prognozi
- biznesning bozor baholash ko'rsatkichlari:
Bozor kapitallashuvi Ventyx Biosciences, Inc|VTYX - Kompaniyani butunlay sotib olishdagi haqiqiy narx
- balans kapitallashuvi bo'yicha ma'lumotlar:
Aksiyaning buxgalteriya qiymati Ventyx Biosciences|VTYX - Balans kapitallashuvi|Balans qiymatiga nisbatan bozor kapitallashuvi ventyxbio.com|VTYX - Kompaniyaning jami aktivlari
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Umumiy qarzning xususiy kapitalga nisbati Ventyx Biosciences|VTYX - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati Ventyx Biosciences Inc.|VTYX - Kompaniyaning umumiy qarzi|Balans kapitallashuviga qarzlar Ventyx Biosciences, Inc|VTYX - Kompaniyaning uzoq muddatli qarzi|Kompaniyaning qisqa muddatli qarzdorligi Ventyx Biosciences|Shoshilinch likvidlik ventyxbio.com
- sof daromad va qiymat multiplikatorlari ko'rsatkichlari:
VTYX - Sof daromad
Kompaniyaning jamlanma tahlili:Ventyx Biosciences
Ventyx Bio asosiy tovari

Professional aktivlarni tanlash biznesning haqiqiy operatsion samaradorligini tekshirishdan boshlanadi. Ushbu metrika buxgalteriya to'xtatishlari uchun tuzatilgan sof daromad ulushini o'lchaydi, bu GURU.Markets platformasida kompaniyaning yakuniy foydasida aks etgan. Investorlar haddan tashqari ko'p to'lov qilishdan qochish uchun ushbu tendentsiyani qarz yuklamasi bilan solishtirishlari kerak. Sog'liqni saqlash gigantlari bilan tuzilgan litsenziyalash shartnomalari Ventyx Biosciences (VTYX) barqarorligini ta'minlaydi. Bunday kelishuvlar ishlab chiqish risklarini minimallashtirib, erkin pul oqimining uzoq muddatli kirishini kafolatlaydi.

Asosiy raqobatchilar

Sof daromad argenx BVBA|BNTX (BioNTech SE) - Sof foyda|Sof foyda Abivax Pharma|Sof daromad ADMA (ADMA Biologics, Inc.)|PTGX (Protagonist Therapeutics, Inc.) - Yakuniy foyda|Sof foyda IMVT (Immunovant Corp)|Sof moliyaviy natija Kiniksa Corp (KNSA)|GRFS - Kompaniyaning sof foydasi|adaptivebiotech.com (ADPT) - Sof daromad|Celldex Therapeutics, Inc. (CLDX) - Kompaniyaning sof foydasi|Sof daromad Aurinia Pharmaceuticals Inc|Sof daromad BCRX|Sof foyda Vera Corp|Kompaniyaning sof foydasi Dianthus Therapeutics (DNTH)|pharvaris.com - Kompaniya foydasi|Sof foyda ABCL (AbCellera Biologics Inc)|Tourmaline Bio Inc (TRML) - Kompaniyaning sof daromadi|PGEN: Sof daromad|PHAR: Kompaniyaning sof foydasi|NKTR: Sof foyda|Kompaniyaning sof daromadi upstreambio.com (UPB)|Kompaniyaning sof foydasi Zenas Biopharma|Kompaniya foydasi IMNM (Immunome Inc)|Sof daromad GOSS (Gossamer Corp)|Soliqlar to‘langandan keyingi foyda KALV|Septerna Inc - Sof daromad|pieris.com (PVLA) - Kompaniyaning sof daromadi|SVRA: Sof daromad|RIGL (Rigel Pharma) - Kompaniya foydasi|ANAB (AnaptysBio Corp) - Sof daromad|Astria Corp - Yakuniy foyda|ENGN (enGene Holdings Inc.) - Sof foyda|Kompaniyaning sof foydasi RAPT|Sof foyda JBIO|Sof moliyaviy natija Aclaris Therapeutics Inc.|Kompaniyaning sof foydasi Kyverna KYTX|Tiziana Life Sciences, Ltd. (TLSA) - Kompaniyaning sof daromadi|CABA - Kompaniyaning sof foydasi|Sof moliyaviy natija theratech.com THTX|AVTX: Sof foyda|Sof daromad Eledon Pharmaceuticals Inc.|AGEN (Agenus Inc) - Sof foyda|Climb Bio, Inc (CLYM) - Sof moliyaviy natija|Sof foyda ZURA|ATYR - Kompaniyaning sof daromadi|Kompaniyaning sof foydasi Adagene Inc. ADAG|IMA: Kompaniya foydasi|Shattuck Therapeutics - Sof foyda|Equillium, Inc. (EQ) - Sof daromad|CNTB: Sof foyda|Kompaniyaning sof daromadi Immunic (IMUX)|Kompaniyaning sof foydasi Atara Biotherapeutics, Inc.|InflaRx GmbH (IFRX) - Sof moliyaviy natija|Sof daromad XFOR (X4 Pharma)|Kompaniyaning sof foydasi ACET (adicetbio.com)|Celularity - Sof daromad|Soliqlar to‘langandan keyingi foyda INMB (inmunebio.com)|BRNS: Sof daromad|Kompaniyaning sof daromadi Kezar Life Sciences Inc.|SABS (SAB Biotherapeutics, Inc) - Sof daromad|Kompaniya foydasi AKTX|Kompaniyaning sof foydasi Enlivex Therapeutics Ltd|Q32 Bio Corp - Soliqdan keyingi foyda|Sof foyda GOVX|EDSA (Edesa Biotech Inc) - Yakuniy foyda|Sof foyda IBIO (iBio Corp)|Sof foyda Carisma Therapeutics Inc CARM|XTLB - Kompaniyaning sof foydasi|Yakuniy foyda BOLT (Bolt Biotherapeutics)|hcwbiologics.com (HCWB) - Kompaniyaning sof foydasi|Sof daromad Aptevo Therapeutics Inc.|AIM (AIM ImmunoTech) - Sof foyda|Sof foyda Aditxt Corp|Sof daromad GRI (GRI Bio, Inc.)|XRTX (xortx.com) - Yakuniy foyda|Sof foyda HIND (Vyome Holdings)|Sof moliyaviy natija Revelation Biosciences Inc (REVB)|INDP - Kompaniyaning sof foydasi|BiondVax Pharmaceuticals (SCNI) - Sof daromad|calcimedica.com (CALI) - Kompaniyaning sof foydasi|Sof daromad Affimed N.V.|Sof daromad ALLK|Sof foyda HOOKIPA|Kompaniyaning sof foydasi IGM Biosciences, Inc. (IGMS)|iTeos Pharma - Kompaniya foydasi|Sof foyda OCEA (Ocean Biomedical, Inc.)|tcbiopharm.com (TCBP) - Kompaniyaning sof daromadi|THRD: Sof daromad